Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 20, 2023

BUY
$96.41 - $126.61 $8,291 - $10,888
86 Added 614.29%
100 $10,000
Q1 2023

May 05, 2023

SELL
$135.66 - $197.02 $135 - $197
-1 Reduced 6.67%
14 $2,000
Q4 2022

Jan 23, 2023

BUY
$118.38 - $210.04 $1,657 - $2,940
14 Added 1400.0%
15 $0
Q2 2022

Aug 01, 2022

BUY
$117.13 - $176.59 $117 - $176
1 New
1 $0
Q1 2022

Apr 29, 2022

SELL
$126.46 - $235.05 $126 - $235
-1 Closed
0 $0
Q4 2021

Feb 03, 2022

SELL
$225.82 - $368.51 $451 - $737
-2 Reduced 66.67%
1 $0
Q4 2020

Feb 02, 2021

BUY
$65.74 - $169.86 $197 - $509
3 New
3 $0

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Moisand Fitzgerald Tamayo, LLC Portfolio

Follow Moisand Fitzgerald Tamayo, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moisand Fitzgerald Tamayo, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moisand Fitzgerald Tamayo, LLC with notifications on news.